S
10.85
-0.52 (-4.57%)
| 前收盘价格 | 11.37 |
| 收盘价格 | 11.30 |
| 成交量 | 318,913 |
| 平均成交量 (3个月) | 1,118,456 |
| 市值 | 483,457,568 |
| 预期市盈率 (P/E Forward) | 10.74 |
| 价格/销量 (P/S) | 493.62 |
| 股市价格/股市净资产 (P/B) | 1.21 |
| 52周波幅 | |
| 利润日期 | 15 May 2025 |
| 营业利益率 (TTM) | -11,831.05% |
| 稀释每股收益 (EPS TTM) | -1.78 |
| 季度收入增长率 (YOY) | -30.90% |
| 总债务/股东权益 (D/E MRQ) | 6.25% |
| 流动比率 (MRQ) | 32.19 |
| 营业现金流 (OCF TTM) | -74.10 M |
| 杠杆自由现金流 (LFCF TTM) | -25.69 M |
| 资产报酬率 (ROA TTM) | -17.20% |
| 股东权益报酬率 (ROE TTM) | -30.96% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看跌 | 看跌 |
| Biotechnology (全球的) | 看跌 | 看跌 | |
| 股票 | Septerna, Inc. | 看跌 | - |
AIStockmoo 评分
0.9
| 分析师共识 | 1.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 2.0 |
| 平均 | 0.88 |
|
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 2.64% |
| 机构持股比例 | 105.46% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Trv Gp V, Llc | 31 Mar 2025 | 6,215,591 |
| Trv Gp Vi, Llc | 31 Mar 2025 | 4,211,659 |
| Avoro Capital Advisors Llc | 31 Mar 2025 | 1,337,500 |
| Catalio Capital Management, Lp | 31 Mar 2025 | 1,024,245 |
| Checkpoint Capital L.P. | 31 Mar 2025 | 824,878 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 26.00 (HC Wainwright & Co., 139.63%) | 购买 |
| 中 | 25.00 (130.42%) | |
| 低 | 18.00 (Wells Fargo, 65.90%) | 保留 |
| 平均值 | 23.00 (111.98%) | |
| 总计 | 2 购买, 1 保留 | |
| 平均价格@调整类型 | 10.07 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 23 Jun 2025 | 26.00 (139.63%) | 购买 | 10.53 |
| Cantor Fitzgerald | 16 May 2025 | 25.00 (130.41%) | 购买 | 9.84 |
| Wells Fargo | 16 May 2025 | 18.00 (65.90%) | 保留 | 9.84 |
该时间范围内无数据。
| 日期 | 类型 | 细节 |
|---|---|---|
| 29 May 2025 | 公告 | Septerna to Present at Jefferies Global Healthcare Conference |
| 15 May 2025 | 公告 | Septerna Highlights Business Progress and Reports First Quarter 2025 Financial Results |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合